SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Susan B. Anthony

PatientSusan B. Anthony
Date of birth1941-02-15
IdentifiersMRN HR-NI014-SYN; SSN (made up) 000-14-7302
Document date2026-03-16
AuthorHarold Pemberton, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for primary care visit for breathlessness on exertion and ankle swelling. [S]

Objective

NT-proBNP: 1650 pg/mL (high); Sodium: 138 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.88 mg/dL; eGFR: 64 mL/min/1.73 m²; Glucose: 96 mg/dL; Magnesium: 2 mg/dL; Hemoglobin: 12.4 g/dL; Ferritin: 140 ng/mL; Transferrin saturation: 24%; TSH: 2.4 mIU/L; HbA1c: 5.5%; LDL cholesterol: 96 mg/dL; ALT: 18 U/L; KCCQ-12 overall summary: 52; PHQ-2: 0. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-03-16Body height165cmS
2026-03-16Body weight58.5kgS
2026-03-16Body mass index (BMI) [Ratio]21.5kg/m2S
2026-03-16Systolic blood pressure158mm[Hg]S
2026-03-16Diastolic blood pressure86mm[Hg]S
2026-03-16Heart rate84/minS
2026-03-16Respiratory rate20/minS
2026-03-16Body temperature36.7CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-16Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma1650pg/mL<=125 pg/mLHighS
2026-03-16Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-03-16Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-03-16Creatinine [Mass/volume] in Serum or Plasma0.88mg/dL0.59-1.04 mg/dLNormalS
2026-03-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M64mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-16Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-03-16Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.6-2.6 mg/dLNormalS
2026-03-16Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
2026-03-16Ferritin [Mass/volume] in Serum or Plasma140ng/mL30-400 ng/mLNormalS
2026-03-16Iron saturation [Mass Fraction] in Serum or Plasma24%20-50%NormalS
2026-03-16Thyrotropin [Units/volume] in Serum or Plasma2.4m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-16Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-03-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation96mg/dL<=99 mg/dLNormalS
2026-03-16Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-35 U/LNormalS
2026-03-16Overall summary score [KCCQ-12]52{score}S
2026-03-16Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Furosemide 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-16 to 2026-06-29completedS
Empagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-16activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Heart failure with preserved ejection fraction, NYHA class II to III at diagnosis; synthetic modern diagnosis linked to the documented 1906 heart failureactiveconfirmed I50.32S — Synthetic diagnosis confirmed by echocardiogram in the modern episode; the 1906 cause of death remains D.
Hypertensive heart disease with heart failureactiveconfirmed I11.0S — Synthetic diagnosis; no blood pressure from her lifetime is recorded in the cited sources.

Assessment

Plan of Treatment